{"DataElement":{"publicId":"14540961","version":"1","preferredName":"Hematopoietic Cell Transplantation Disease or Disorder Indication Mixed Phenotype Acute Leukemia Reason","preferredDefinition":"The specific indication for the hematopoietic cell transplantation for mixed phenotype acute leukemia.","longName":"HCT_IND_MPAL_REA","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"10404358","version":"1","preferredName":"Hematopoietic Cell Transplantation Disease or Disorder Indication","preferredDefinition":"A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).","longName":"2659877v1.00:10404357v1.00","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2659877","version":"1","preferredName":"Stem Cell Transplantation","preferredDefinition":"A method of replacing the immature blood-forming cells lost due to high-dose chemotherapy, and possibly radiation therapy, used to destroy leukemia cells.  The stem cells are given to the patient after treatment to help the bone marrow recover and continue producing healthy blood cells.","longName":"C15431","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic Cell Transplantation","conceptCode":"C15431","definition":"A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"33BBDBD7-E7FD-4A2E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-25","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2007-06-25","modifiedBy":"ONEDATA","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"10404357","version":"1","preferredName":"Disease or Disorder Indication","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).","longName":"C2991:C41184","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indication","conceptCode":"C41184","definition":"A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFDCA1E9-3221-2FB2-E053-731AD00A0138","latestVersionIndicator":"Yes","beginDate":"2022-06-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-01","modifiedBy":"KUMMEROA","dateModified":"2022-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFDCA1E9-3222-2FB2-E053-731AD00A0138","latestVersionIndicator":"Yes","beginDate":"2022-06-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-01","modifiedBy":"KUMMEROA","dateModified":"2022-08-22","changeDescription":null,"administrativeNotes":"2022.8.22 Released. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"14540951","version":"1","preferredName":"Mixed Phenotype Acute Leukemia Hematopoietic Cell Transplantation Indication Reason","preferredDefinition":"An acute leukemia of ambiguous lineage.  It is characterized by the presence of either separate populations of blasts of more than one lineage, or one population of blasts co-expressing markers of more than one lineage._A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases._A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication)._An explanation of the cause of some phenomenon or action.","longName":"14540951v1.00","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":null,"ValueMeaning":{"publicId":"5611398","version":"1","preferredName":"Other","longName":"5611398","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"44E429E5-2CE2-4AE2-E053-F662850A4EE8","latestVersionIndicator":"Yes","beginDate":"2016-12-30","endDate":null,"createdBy":"ALEYR","dateCreated":"2016-12-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0801A308-8436-04B7-E063-731AD00ACEA6","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","deletedIndicator":"No"},{"value":"CR2 or greater","valueDescription":null,"ValueMeaning":{"publicId":"14540953","version":"1","preferredName":"Greater Than or Equal To Second Complete Remission","longName":"14540953v1.00","preferredDefinition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways._Coming next after the first in position in space or time or degree or magnitude._The disappearance of all signs of cancer in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than or Equal To","conceptCode":"C61583","definition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Second","conceptCode":"C25666","definition":"Coming next after the first in position in space or time or degree or magnitude.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0801A308-8434-04B7-E063-731AD00ACEA6","latestVersionIndicator":"Yes","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0801A308-8437-04B7-E063-731AD00ACEA6","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","deletedIndicator":"No"},{"value":"Treated with AML therapy","valueDescription":null,"ValueMeaning":{"publicId":"14540954","version":"1","preferredName":"Acute Myeloid Leukemia Therapeutic Procedure Treat","longName":"14540954v1.00","preferredDefinition":"A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues. The classification of acute myeloid leukemias (AMLs) encompasses four major categories: 1) AML with recurrent genetic abnormalities; 2) AML with multilineage dysplasia; 3) Therapy-related AML; 4) AML not otherwise specified. The required bone marrow or peripheral blood blast percentage for the diagnosis of AML is 20% (WHO classification)._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._Subject to a process with the aim of readying for some purpose, improving, or remedying a condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Myeloid Leukemia","conceptCode":"C3171","definition":"A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues. The classification of acute myeloid leukemias (AMLs) encompasses four major categories: 1) AML with recurrent genetic abnormalities; 2) AML with multilineage dysplasia; 3) Therapy-related AML; 4) AML not otherwise specified. The required bone marrow or peripheral blood blast percentage for the diagnosis of AML is 20% (WHO classification).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Treat","conceptCode":"C70742","definition":"Subject to a process with the aim of readying for some purpose, improving, or remedying a condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0801A308-8435-04B7-E063-731AD00ACEA6","latestVersionIndicator":"Yes","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0801A308-8438-04B7-E063-731AD00ACEA6","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","deletedIndicator":"No"},{"value":"CR1 induction failure to ALL therapy","valueDescription":null,"ValueMeaning":{"publicId":"14540955","version":"1","preferredName":"Acute Lymphoblastic Leukemia Therapeutic Procedure Complete Remission One Induction Failure","longName":"14540955v1.00","preferredDefinition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._The disappearance of all signs of cancer in response to treatment._The smallest natural number and quantity it denotes: a single entity, unit, or object._The act of bringing about something._A lack of occurrence or performance.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Lymphoblastic Leukemia","conceptCode":"C3167","definition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"One","conceptCode":"C66832","definition":"The smallest natural number and quantity it denotes: a single entity, unit, or object.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Induction","conceptCode":"C61367","definition":"The act of bringing about something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0801C41B-200D-0AE6-E063-731AD00AC9B0","latestVersionIndicator":"Yes","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0801C41B-200F-0AE6-E063-731AD00AC9B0","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","deletedIndicator":"No"},{"value":"CR1 treatment failure","valueDescription":null,"ValueMeaning":{"publicId":"14540956","version":"1","preferredName":"Complete Remission One Treatment Failure","longName":"14540956v1.00","preferredDefinition":"The disappearance of all signs of cancer in response to treatment._The smallest natural number and quantity it denotes: a single entity, unit, or object._A lack of response to therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"One","conceptCode":"C66832","definition":"The smallest natural number and quantity it denotes: a single entity, unit, or object.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Treatment Failure","conceptCode":"C200647","definition":"A lack of response to therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0801C41B-200E-0AE6-E063-731AD00AC9B0","latestVersionIndicator":"Yes","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0801C41B-2010-0AE6-E063-731AD00AC9B0","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","deletedIndicator":"No"},{"value":"Induction failure","valueDescription":null,"ValueMeaning":{"publicId":"3226263","version":"1","preferredName":"Induction Failure","longName":"3226263","preferredDefinition":"The act of bringing about something.: loss of ability to function normally.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Induction","conceptCode":"C61367","definition":"The act of bringing about something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A05C1385-BC56-A102-E040-BB89AD431226","latestVersionIndicator":"Yes","beginDate":"2011-04-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-07","modifiedBy":"KUMMEROA","dateModified":"2023-10-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0801C41B-2011-0AE6-E063-731AD00AC9B0","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435032","version":"1","preferredName":"Property or Attribute","preferredDefinition":"The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.","longName":"C20189","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-8321-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"14540950","version":"1","preferredName":"Mixed Phenotype Acute Leukemia Hematopoietic Cell Transplantation Indication Reason","preferredDefinition":"An acute leukemia of ambiguous lineage.  It is characterized by the presence of either separate populations of blasts of more than one lineage, or one population of blasts co-expressing markers of more than one lineage._A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases._A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication)._An explanation of the cause of some phenomenon or action.","longName":"14540950v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Phenotype Acute Leukemia","conceptCode":"C82179","definition":"An acute leukemia of ambiguous lineage.  It is characterized by the presence of either separate populations of blasts of more than one lineage, or one population of blasts co-expressing markers of more than one lineage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Hematopoietic Cell Transplantation","conceptCode":"C15431","definition":"A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Indication","conceptCode":"C41184","definition":"A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"08019698-4289-027A-E063-731AD00A389E","latestVersionIndicator":"Yes","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"08019698-428A-027A-E063-731AD00A389E","latestVersionIndicator":"Yes","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-26","changeDescription":null,"administrativeNotes":"2023.10.26 Released per quarterly report. ak2023.10.18 Created per ticket request CADSR0002976. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What was the indication for the hematopoietic cell transplantation for mixed phenotype acute leukemia?","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Select the specific indication for HCT:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0801FC0B-6F5D-177F-E063-731AD00A6086","latestVersionIndicator":"Yes","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-26","changeDescription":null,"administrativeNotes":"2023.10.26 Released. ak2023.10.18 Created per ticket request CADSR0002976. ak","unresolvedIssues":null,"deletedIndicator":"No"}}